Full Prescribing Info
Cervarix is indicated in females from 9 through 25 years of age for the prevention of persistent infection, premalignant cervical lesions and cervical cancer (squamous cell carcinoma and adenocarcinoma) caused by oncogenic Human Papillomavirus (HPV) types 16, and 18 (see Pharmacology: Pharmacodynamics under Actions and Precautions for more information on HPV 16, 18 and other oncogenic types).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in